Literature DB >> 11430534

Antagonization of tumor necrosis factor in snake bite. A new approach for an old threat.

F Abroug, S Nouira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11430534     DOI： 10.1007/s001340100928

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  17 in total

1.  Time factor in the detection of circulating whole venom and crotoxin and efficacy of antivenom therapy in patients envenomed by Crotalus durissus.

Authors:  C F Amaral; D Campolina; M B Dias; C M Bueno; C Chávez-Olortegui; C L Penaforte; C R Diniz; N A Rezende
Journal:  Toxicon       Date:  1997-05       Impact factor: 3.033

2.  Antagonization of TNF attenuates systemic hemodynamic manifestations of envenomation in a rat model of Vipera aspis snakebite.

Authors:  O Szold; R Ben-Abraham; A A Weinbroum; T E Englender; D Ovadia; M Sorkine; C Bon; R Flaison; P Sorkine
Journal:  Intensive Care Med       Date:  2001-05       Impact factor: 17.440

3.  A randomized, blinded, comparative trial of one pepsin-digested and two whole IgG antivenoms for Bothrops snake bites in Uraba, Colombia. The Regional Group on Antivenom Therapy Research (REGATHER).

Authors:  R Otero-Patiño; J L Cardoso; H G Higashi; V Nunez; A Diaz; M F Toro; M E Garcia; A Sierra; L F Garcia; A M Moreno; M C Medina; N Castañeda; J F Silva-Diaz; M Murcia; S Y Cardenas; W D Dias da Silva
Journal:  Am J Trop Med Hyg       Date:  1998-02       Impact factor: 2.345

Review 4.  Venoms, antivenoms and immunotherapy.

Authors:  J P Chippaux; M Goyffon
Journal:  Toxicon       Date:  1998-06       Impact factor: 3.033

5.  First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom.

Authors:  W P Meyer; A G Habib; A A Onayade; A Yakubu; D C Smith; A Nasidi; I J Daudu; D A Warrell; R D Theakston
Journal:  Am J Trop Med Hyg       Date:  1997-03       Impact factor: 2.345

6.  Recurrent and persistent coagulopathy following pit viper envenomation.

Authors:  L V Boyer; S A Seifert; R F Clark; J T McNally; S R Williams; S P Nordt; F G Walter; R C Dart
Journal:  Arch Intern Med       Date:  1999-04-12

7.  Early infusion of a purified monospecific F(ab')2 antivenom serum for Bothrops lanceolatus bites in Martinique.

Authors:  L Thomas; B Tyburn; J Lang; J Ketterle
Journal:  Lancet       Date:  1996-02-10       Impact factor: 79.321

8.  Serotherapy in scorpion envenomation: a randomised controlled trial.

Authors:  F Abroug; S ElAtrous; S Nouira; H Haguiga; N Touzi; S Bouchoucha
Journal:  Lancet       Date:  1999-09-11       Impact factor: 79.321

9.  Processing of pro-tumor necrosis factor-alpha by venom metalloproteinases: a hypothesis explaining local tissue damage following snake bite.

Authors:  A M Moura-da-Silva; G D Laing; M J Paine; J M Dennison; V Politi; J M Crampton; R D Theakston
Journal:  Eur J Immunol       Date:  1996-09       Impact factor: 5.532

10.  Serum interleukin-1beta, interleukin-6, nitric oxide and alpha1-antitrypsin in scorpion envenomed children.

Authors:  A R Meki; Z M Mohey El-Dean
Journal:  Toxicon       Date:  1998-12       Impact factor: 3.033
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.